Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Adam Laponis Insider Profile
4 Followers
Adam Laponis, CFO at Eargo, holds 115.98K shares in Twist Bioscience (Ticker: TWST), holds 258.00 shares in Eargo (Ticker: EAR).
Profitable Transactions
1 out of 4 Profitable Transactions
Average Return
+2.40%
Average return per transaction
Time Frame
Compare to
Insider Roles
CFO
Roles that Adam Laponis holds in companies
Most Profitable Insider Trade
Stock:
Eargo
(EAR)
(EAR)
Rating:Informative Sell
Date:Feb 22, 2023 - Feb 22, 2024
Return:+63.60%
The most profitable trade made by Adam Laponis
Adam Laponis's Trading History
Eargo
Nov 22, 2023
―
Uninformative Sell
85.80
$663.06
Twist Bioscience
Dec 06, 2024
CFO
Uninformative Buy
―
$5.56M
List of latest transactions for each holding click on a transaction to see Adam Laponis's performance on stock
You May Also Like
Adam Laponis insider profile FAQ
What is the percentage of profitable transactions made by Adam Laponis?
The percentage of profitable transactions made by Adam Laponis is 25%.
What is the average return per transaction made by Adam Laponis?
The average return per transaction made by Adam Laponis is 2.40%.
What stocks does Adam Laponis hold?
Adam Laponis holds: EAR, TWST stocks.
What was Adam Laponis’s latest transaction?
Adam Laponis latest transaction was an Uninformative Buy of ―.
What was Adam Laponis's most profitable transaction?
Adam Laponis’s most profitable transaction was an Informative Sell of EAR stock on February 22, 2023. The return on the trade was 63.60%.
What is Adam Laponis's role in Eargo?
Adam Laponis's role in Eargo is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.